Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Entos Pharmaceuticals Inc.

Headquarters: Edmonton, AB, Canada
Year Founded: 2017
Status: Private

BioCentury | Sep 26, 2024
Discovery & Translation

Science Spotlight: Targeted protein relocalization, rejuvenating aged eggs, and more

BioCentury’s roundup of translational innovations
BioCentury | Jul 30, 2024
Product Development

Venturing beyond AAVs and LNPs to deliver therapeutic cargo

Dozens of companies aim to avoid immunogenicity and improve tissue-specificity
BioCentury | Mar 5, 2022
Management Tracks

Entos builds out team with Chen as CMO, Ding as CBO

Plus Henderson becomes CEO of Wren, and updates from Bolt, argenx and more
BioCentury | Feb 23, 2022
Product Development

Lilly aims for technology synergies with unified genetic medicines group

The Lilly Institute for Genetic Medicine brings DNA, RNA therapies under one group — and it’s seeking delivery deals 
BioCentury | Jan 6, 2022
Deals

Lilly-Entos deal underscores importance of nucleic acid delivery tech

Partners to use Canadian biotech’s Fusogenix platform for non-viral nucleic acid delivery in neurology
BioCentury | Oct 23, 2021
Product Development

Gene therapy’s next class of biotechs

And the innovative technologies they’re developing
BioCentury | Sep 2, 2020
Product Development

COVID-19 Quick Takes: NAS framework on vaccine allocation prioritizes higher risk groups

Plus Soriot reiterates AZ’s commitment to ‘follow the science,’ deliver equitable access
BioCentury | Jul 18, 2018
Translation in Brief

Playing chicken with metastasis

How a chicken embryo screen identified Entos’ metastasis targets
BioCentury | Jul 18, 2018
Distillery Techniques

Assays and screens

Items per page:
1 - 9 of 9